BioBreakthroughs

Join us on the latest episode! Our Guests: Aaron Mackey, SVP of AI/Data Science at Lokavant & Jonathan Crowther, Head of Predictive Analytics at Pfizer.

What you'll get out of this episode:
  • Causal AI Explained: Aaron Mackey from Lokavant and Jonathan Crowther from Pfizer discuss the capabilities of causal AI in differentiating cause and effect in clinical trials.
  • Comparison to Generative AI: The episode breaks down the distinctions between generative AI and causal AI, highlighting the advantages of causal approaches in clinical operations.
  • Impact on Clinical Trial Feasibility: The experts explain how causal AI optimizes trial feasibility assessments, leading to more efficient and effective clinical processes.
  • Forecasting Clinical Trials with AI: Insight into how causal AI improves data-driven decision-making and addresses the limitations of traditional trial forecasts.

To learn more about our guests and their companies:
Aaron's LinkedIn https://www.linkedin.com/in/aaronmackey/
Jonathan's LinkedIn https://www.linkedin.com/in/crowtherjonathan/

Lokavant LinkedIn https://www.linkedin.com/company/lokavant/
Pfizer LinkedIn https://www.linkedin.com/company/pfizer/

Lokavant Website https://www.lokavant.com/en-us/
Pfizer Website https://www.pfizer.com/


Our sponsor for this episode is:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

What is BioBreakthroughs?

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.